The role of IL-7 and IL-7R in cancer pathophysiology and immunotherapy

Cited 69 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorChunli Wang-
dc.contributor.authorLingzu Kong-
dc.contributor.authorSeokmin Kim-
dc.contributor.authorSunyoung Lee-
dc.contributor.authorSechan Oh-
dc.contributor.authorSeona Cho-
dc.contributor.authorInhwan Jang-
dc.contributor.authorTae-Don Kim-
dc.date.accessioned2022-09-26T16:32:48Z-
dc.date.available2022-09-26T16:32:48Z-
dc.date.issued2022-
dc.identifier.issn1661-6596-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/30384-
dc.description.abstractInterleukin-7 (IL-7) is a multipotent cytokine that maintains the homeostasis of the immune system. IL-7 plays a vital role in T-cell development, proliferation, and differentiation, as well as in B cell maturation through the activation of the IL-7 receptor (IL-7R). IL-7 is closely associated with tumor development and has been used in cancer clinical research and therapy. In this review, we first summarize the roles of IL-7 and IL-7Rα and their downstream signaling pathways in immunity and cancer. Furthermore, we summarize and discuss the recent advances in the use of IL-7 and IL-7Rα as cancer immunotherapy tools and highlight their potential for therapeutic applications. This review will help in the development of cancer immunotherapy regimens based on IL-7 and IL-7Rα, and will also advance their exploitation as more effective and safe immunotherapy tools.-
dc.publisherMDPI-
dc.titleThe role of IL-7 and IL-7R in cancer pathophysiology and immunotherapy-
dc.title.alternativeThe role of IL-7 and IL-7R in cancer pathophysiology and immunotherapy-
dc.typeArticle-
dc.citation.titleInternational Journal of Molecular Sciences-
dc.citation.number18-
dc.citation.endPage10412-
dc.citation.startPage10412-
dc.citation.volume23-
dc.contributor.affiliatedAuthorChunli Wang-
dc.contributor.affiliatedAuthorLingzu Kong-
dc.contributor.affiliatedAuthorSeokmin Kim-
dc.contributor.affiliatedAuthorSunyoung Lee-
dc.contributor.affiliatedAuthorSechan Oh-
dc.contributor.affiliatedAuthorSeona Cho-
dc.contributor.affiliatedAuthorInhwan Jang-
dc.contributor.affiliatedAuthorTae-Don Kim-
dc.contributor.alternativeName왕춘리-
dc.contributor.alternativeName공링주-
dc.contributor.alternativeName김석민-
dc.contributor.alternativeName이선영-
dc.contributor.alternativeName오세찬-
dc.contributor.alternativeName조선아-
dc.contributor.alternativeName장인환-
dc.contributor.alternativeName김태돈-
dc.identifier.bibliographicCitationInternational Journal of Molecular Sciences, vol. 23, no. 18, pp. 10412-10412-
dc.identifier.doi10.3390/ijms231810412-
dc.subject.keywordIL-7-
dc.subject.keywordIL-7R signal-
dc.subject.keywordCancer-
dc.subject.keywordImmunotherapy-
dc.subject.localIL-7-
dc.subject.localCancer-
dc.subject.localCancers-
dc.subject.localcancer-
dc.subject.localImmunotherapy-
dc.subject.localimmunotherapy-
dc.subject.localImmunothrapy-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.